DAVID POPLACK to Meningeal Neoplasms
This is a "connection" page, showing publications DAVID POPLACK has written about Meningeal Neoplasms.
Connection Strength
1.157
-
Neoplastic meningitis: diagnosis and treatment considerations. Med Oncol. 2000 Aug; 17(3):151-62.
Score: 0.154
-
New cytotoxic drugs for intrathecal administration. J Neurooncol. 1998 Jun-Jul; 38(2-3):219-23.
Score: 0.133
-
Pharmacologic strategies for the treatment of meningeal malignancy. Invest New Drugs. 1996; 14(1):69-85.
Score: 0.112
-
Advances in the treatment of meningeal cancers. Crit Rev Oncol Hematol. 1995 Aug; 20(1-2):87-98.
Score: 0.109
-
Intrathecal 6-mercaptopurine: preclinical pharmacology, phase I/II trial, and pharmacokinetic study. Cancer Res. 1991 Nov 15; 51(22):6079-83.
Score: 0.084
-
Pharmacologic approaches to the treatment of meningeal malignancy. Oncology (Williston Park). 1991 May; 5(5):107-16; discussion 123, 127.
Score: 0.081
-
Differences in cerebrospinal fluid penetration of corticosteroids: possible relationship to the prevention of meningeal leukemia. J Clin Oncol. 1987 Feb; 5(2):202-7.
Score: 0.061
-
Remission induction of meningeal leukemia with high-dose intravenous methotrexate. J Clin Oncol. 1985 Apr; 3(4):485-9.
Score: 0.053
-
Intrathecal mafosfamide: a preclinical pharmacology and phase I trial. J Clin Oncol. 2005 Mar 01; 23(7):1555-63.
Score: 0.053
-
Phase I clinical trial of intrathecal topotecan in patients with neoplastic meningitis. J Clin Oncol. 2003 Jan 01; 21(1):143-7.
Score: 0.046
-
The effects of prophylactic treatment of the central nervous system on the intellectual functioning of children with acute lymphocytic leukemia. Am J Med. 1981 Jul; 71(1):47-52.
Score: 0.041
-
Intraventricular concentration times time (C x T) methotrexate and cytarabine for patients with recurrent meningeal leukemia and lymphoma. Cancer. 1999 Jan 15; 85(2):511-6.
Score: 0.035
-
Acute encephalopathy after initiation of cranial irradiation for meningeal leukaemia. Lancet. 1978 Jul 01; 2(8079):13-5.
Score: 0.033
-
The Ommaya reservoir: newly recognized complications and recommendations for insertion and use. Cancer. 1978 Jun; 41(6):2431-7.
Score: 0.033
-
Central nervous system leukemia. Curr Opin Oncol. 1996 Jan; 8(1):13-9.
Score: 0.028
-
Current pharmacological treatment approaches to central nervous system leukaemia. Drugs. 1991 May; 41(5):702-16.
Score: 0.020
-
Acute lymphoblastic leukemia in childhood. Pediatr Clin North Am. 1988 Aug; 35(4):903-32.
Score: 0.017
-
Altered central nervous system pharmacology of methotrexate in childhood leukemia: another sign of meningeal relapse. J Clin Oncol. 1985 Jan; 3(1):19-24.
Score: 0.013
-
Cytosine arabinoside cerebrospinal fluid kinetics. Clin Pharmacol Ther. 1984 Jun; 35(6):826-30.
Score: 0.013
-
Cerebrospinal fluid pharmacokinetics of intraventricular and intravenous aziridinylbenzoquinone. Cancer Res. 1984 Apr; 44(4):1698-701.
Score: 0.012
-
"Concentration x time" methotrexate via a subcutaneous reservoir: a less toxic regimen for intraventricular chemotherapy of central nervous system neoplasms. Blood. 1978 May; 51(5):835-42.
Score: 0.008
-
Abnormal CT scans of the brain in asymptomatic children with acute lymphocytic leukemia after prophylactic treatment of the central nervous system with radiation and intrathecal chemotherapy. N Engl J Med. 1978 Apr 13; 298(15):815-8.
Score: 0.008
-
Meningeal relapse of orbital rhabdomyosarcoma. Med Pediatr Oncol. 1978; 4(3):247-51.
Score: 0.008